SCHEMBL30417693

SCHEMBL30417693

Cn1cnc2cc(C(=O)O)cc(F)c21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.42
HCAR3 P49019 2/20 0.40
KDM4C Q9H3R0 6/20 0.39
KDM4A O75164 1/20 0.39
KDM5A P29375 1/20 0.39
KDM5B Q9UGL1 1/20 0.39
KDM2B Q8NHM5 3/20 0.38
HPGD P15428 2/20 0.38
FGFR1 P11362 2/20 0.37
GRM5 P41594 1/20 0.36
KMT2A Q03164 1/20 0.36
LMNA P02545 2/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36
ALDH1A1 P00352 2/20 0.35
DPP4 P27487 1/20 0.35
HSD17B10 Q99714 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30158927 0.83 POLB (0.48) HPGDFGFR1GRM5KMT2ALMNA
SCHEMBL21820598 0.81 KDM2B (0.43) HCAR3KDM4CKDM2BHPGDFGFR1
SCHEMBL28839533 0.78 CA12 (0.49) HCAR3KDM4CKDM5AKDM5BKDM2B
SCHEMBL29850787 0.78 CA12 (0.49) HCAR3KDM4CKDM5AKDM5BKDM2B
SCHEMBL31257412 0.76 ESR1 (0.38) ALDH1A1DPP4MAPT
SCHEMBL30158867 0.76 HSD17B10 (0.52) THRBHCAR3HPGDFGFR1ALDH1A1
SCHEMBL21187466 0.75 DPP4 (0.47) GRM5MAPK1DPP4
SCHEMBL27957358 0.74 KDM4C (0.39) THRBHCAR3KDM4CKDM4AKDM5A
SCHEMBL24807695 0.74 DPP4 (0.39) HPGDFGFR1KMT2ARAB9AALDH1A1
SCHEMBL21820476 0.74 ABL1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4433477-A1 PAD4 INHIBITORS AND USE THEREOF Regor Pharmaceuticals, Inc. (US) 2024-09-25 EP disclosed
CN-118679162-A PAD4 inhibitors and uses thereof 锐格药业公司 2024-09-20 CN disclosed
WO-2023083365-A1 PAD4 INHIBITORS AND USE THEREOF QILU REGOR THERAPEUTICS INC. (CN) 2023-05-19 WO disclosed